The world's leading automated proofreading software

Medical Devices Regulation EU 2017/745

Published By: Mike Baird

2 minutes read
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Table of Contents

Medical Devices Regulation (MDR) updates represent a step towards higher labeling standards. At the same time, they create challenges and a potential need for additional resources. Instructions for Use (IFU) must be flawless, not only because they need to comply with regulation to avoid legal liabilities, but above all, to ensure optimal use of the medical device.

Annex I Chapter III of the MDR summarizes the requirements for labeling, including the IFU. MDR requirements on user and patient labeling are highly user centric. IFUs must not only be safe and transparent, it is essential they are also clear, understandable and accurate.

Risks, limitations, contraindications, precautions, warnings and special storage conditions are required to be communicated to the user immediately upon first contact with the packed device – which means directly on the label, prior to unpacking. In cases where directions are too large for a device label, they need to be completely and properly explained in the IFU. For example, MDR, compared to the former Medical Device Directive (MDD), requires stringent instructions on how to declare and handle sterile packaging. These instructions require additional clearly explained directions in the IFU.

IFUs that are up to date, well-structured and easily understood are not only important from a scientific perspective but are also valuable from a marketing perspective. IFUs that are not easily understood or that lead to incorrect usage negatively impact sales. A medical device that is not easy to use because of a suboptimal IFU is also not an easy sell.

Using an automated proofreading solution will help ensure documents are completely and accurately updated. Text verification tools will also assist in reducing time spent reviewing what are often large and complex IFU updates by up to 85%, reducing the requirement for additional resources.

Interested in knowing more? Read the ROI whitepaper:

Do you want to find out more about how your proofreading life can be easier? Get in touch and we’ll tell you all about it.

Share this article

Mike Baird profile picture

Mike Baird

Director of Product Management, Schlafender Hase

Mike is the Director of Product Management for Schlafender Hase.

Learn More

Subscribe to our blog

Do you want to find out more about how your proofreading life can be easier? Get in touch and we’ll tell you all about it.

Subscribe to our blog

Related Blogs

How FMCG and CPG Companies Can Improve Regulatory Risk Management for Packaging

June 12, 2025

Schlafender Hase Team

How FMCG and CPG Companies Can Improve Regulatory Risk Management for Packaging

In the rapidly changing and highly competitive Fast-Moving Consumer Goods (FMCG) sector, labeling and packaging plays an important role in brand identity, over and above its purpose of protecting the physical product.

How FMCG and CPG Companies Can Improve Regulatory Risk Management for Packaging
5 minutes read

How FMCG and CPG Companies Can Improve Regulatory Risk Management for Packaging

In the rapidly changing and highly competitive Fast-Moving Consumer Goods (FMCG) sector, labeling and packaging plays an important role in brand identity, over and above its purpose of protecting the physical product.

E-labeling and what it means for regulatory teams

May 29, 2025

Schlafender Hase Team

RAPS Webinar: e-Labeling and what it means for Regulatory Teams

E-labeling is no longer a future concept. Regulatory agencies worldwide, including the EMA, FDA, and MHRA, are advancing digital product information initiatives. But what does this mean for your daily work as a regulatory professional? How will your submission and labeling processes change? And how can you prepare today to avoid last-minute compliance risks?

E-labeling and what it means for regulatory teams
2 minutes read

RAPS Webinar: e-Labeling and what it means for Regulatory Teams

E-labeling is no longer a future concept. Regulatory agencies worldwide, including the EMA, FDA, and MHRA, are advancing digital product information initiatives. But what does this mean for your daily work as a regulatory professional? How will your submission and labeling processes change? And how can you prepare today to avoid last-minute compliance risks?

Press Release Cloud Native TVT

May 28, 2025

Schlafender Hase Team

Schlafender Hase Brings Pharma-Level content review and compliance to the CPG Industry with a new cloud-native version of TVT

TVT, Schlafender Hase’s flagship software, has long been the trusted standard for document and label review in the pharmaceutical industry. The new cloud-native version builds on the same proven comparison engine at the core of the desktop product. With a responsive web interface, scalable microservices architecture, and standards-based RESTful APIs, it delivers enhanced flexibility, intuitive usability, and seamless integration with existing document and artwork management systems, making world-class quality control more accessible to CPG teams.

Press Release Cloud Native TVT
2 minutes read

Schlafender Hase Brings Pharma-Level content review and compliance to the CPG Industry with a new cloud-native version of TVT

TVT, Schlafender Hase’s flagship software, has long been the trusted standard for document and label review in the pharmaceutical industry. The new cloud-native version builds on the same proven comparison engine at the core of the desktop product. With a responsive web interface, scalable microservices architecture, and standards-based RESTful APIs, it delivers enhanced flexibility, intuitive usability, and seamless integration with existing document and artwork management systems, making world-class quality control more accessible to CPG teams.